Additionally, in a study involving 129 CSF samples from patients in Scandinavia, the α-synuclein seed amplification assay successfully distinguished between synucleinopathies (such as PD and MSA) and tauopathies (such as CBD and PSP) [55]. This evidence concerns the gene SNCA and multiple system atrophy.